Most commercially available hormones are designed for population-level dosing - one-size-fits-all, and no room for personalization.
But hormones don’t behave at the population level. Human bodies are uniquely shaped by metabolism, liver function, toxin exposure, and how each person absorbs and processes hormones.
And yet, the commercial market still tries to solve for all of that complexity with a limited set of fixed doses.
Take something as common as an estradiol patch. It only comes in a handful of options. So what happens if your body needs something in between?
That gap is where a lot of people get stuck. They’re technically “on hormones,” but they don’t feel right, they don’t respond the way they should, or they’re dealing with side effects that don’t make sense.
At the same time, we’re seeing a new wave of messaging that says hormones are now “safe,” and therefore easy to prescribe. But that creates a second problem. Because hormones aren’t inherently safe or unsafe; they’re precise.
And when you remove the precision, the testing, and the individualization, you don’t get better outcomes. You just get more people on a one-size-fits-all approach that was never designed to fit them in the first place.
So the real question becomes: if standardized options fall short, what does it actually take to get hormones that actually match what your body needs?
In this episode, speaker, author, educator, and Anti-Aging and Precision Medicine expert, Dr. Pamela Smith, returns. Today, we’re breaking down why compounding isn’t an alternative approach; it’s often the only way to truly match treatment to the patient.
Things You’ll Learn In This Episode
Hormones don’t follow averages
Most medications are designed for population-level outcomes, but hormones are influenced by metabolism, weight, liver function, toxins, and more. What happens when we treat something highly individualized with standardized protocols?
Convenience is replacing clinical rigor
From telehealth checklists to “no-testing” approaches, hormone therapy is becoming easier to access, but less precise. Are we improving care, or just scaling shortcuts?
Why “normal dosing” often fails patients
Small changes like weight fluctuations or absorption differences can shift hormone needs significantly. If dosing isn’t adjusted at a micro level, how many patients are being under- or over-treated without realizing it?
Hormones aren’t the starting point; they’re the amplifier
When upstream issues like toxins, gut health, or metabolic dysfunction aren’t addressed, hormone therapy often fails. Are we blaming hormones when the real issue is everything around them?
PS. If you enjoy the show, remember to leave a review on your favorite podcast app! Reviews help the podcast reach a wider audience and help more people.